Lafora Disease and Congenital Generalized Lipodystrophy: A Case Report
暂无分享,去创建一个
[1] S. O’Rahilly,et al. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. , 2008, The Journal of clinical endocrinology and metabolism.
[2] C. Ackerley,et al. Typical progression of myoclonic epilepsy of the Lafora type: a case report , 2008, Nature Clinical Practice Neurology.
[3] A. Delgado-Escueta. Advances in Lafora progressive myoclonus epilepsy , 2007, Current neurology and neuroscience reports.
[4] S. Ling,et al. Lafora-Like Ground-Glass Inclusions in Hepatocytes of Pediatric Patients: A Report of Two Cases , 2007, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[5] L. Wilkins. Genetic diagnosis in Lafora disease: Genotype–phenotype correlations and diagnostic pitfalls , 2007, Neurology.
[6] K. Yamakawa,et al. Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment. , 2007, Human molecular genetics.
[7] A. K. Agarwal,et al. Genetic basis of lipodystrophies and management of metabolic complications. , 2006, Annual review of medicine.
[8] S. Scherer,et al. Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy. , 2005, Human molecular genetics.
[9] C. Worby,et al. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Scherer,et al. Progressive myoclonus epilepsy with polyglucosans (Lafora disease) , 2004, Neurology.
[11] J. Serratosa,et al. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. , 2003, Human molecular genetics.
[12] S. O’Rahilly,et al. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy , 2002, Journal of medical genetics.
[13] J. Papp,et al. Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13 , 2001, Nature Genetics.
[14] B. Minassian. Lafora's disease: towards a clinical, pathologic, and molecular synthesis. , 2001, Pediatric neurology.
[15] K. Yamakawa,et al. Advances in the genetics of progressive myoclonus epilepsy. , 2001, American journal of medical genetics.
[16] S. Scherer,et al. Mutation spectrum and predicted function of laforin in Lafora’s progressive myoclonus epilepsy , 2000, Neurology.
[17] S. Scherer,et al. Identification of new and common mutations in the EPM2A gene in Lafora disease , 2000, Neurology.
[18] A. Bowcock,et al. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. , 1999, The Journal of clinical endocrinology and metabolism.
[19] D. Rénier,et al. Axilla skin biopsy: A reliable test for the diagnosis of Lafora's disease , 1987, Annals of neurology.
[20] S. Carpenter,et al. Sweat gland duct cells in Lafora disease , 1981, Neurology.
[21] M. Seip. Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome? , 1959, Acta paediatrica.
[22] M. Seip. 38. Congenital Hyperpituitarism of Hypothalamic Origin; A new Diencephalic Syndrome with Endocrine Manifestations , 1959, Acta paediatrica. Supplementum.
[23] W. Berardinelli. An undiagnosed endocrinometabolic syndrome: report of 2 cases. , 1954, The Journal of clinical endocrinology and metabolism.
[24] S. Scherer,et al. On the road to tractability: the current biochemical understanding of progressive myoclonus epilepsies. , 2006, Advances in neurology.
[25] A. Beydoun,et al. Biopsy results in a kindred with Lafora disease. , 1993, Archives of neurology.